Skip to main content
SpringerLink
Log in

Malignant Mesothelioma Following Radiation

  • Chapter
Book cover Malignant Mesothelioma

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med 1960;17:260–271.

    PubMed  CAS  Google Scholar 

  2. Selikoff IJ. Cancer risk of asbestos exposure. In: Hiatt HH, Watson JD, Winsten JA, eds. Origins of Human Cancer. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1977:1765–1784.

    Google Scholar 

  3. Peterson JT, Greenberg SD, Buffler PA. Non-asbestos-related malignant mesothelioma, a review. Cancer 1984;54:951–960.

    Article  PubMed  Google Scholar 

  4. Carbone M, Fisher S, Powers A, Pass HI, Rizzo P. New molecular and epidemiological issues in mesothelioma: role of SV40. J Cell Physiol 1999;180:167–172.

    Article  PubMed  CAS  Google Scholar 

  5. Mulatero C, Surentheran T, Breuer J, Rudd RM. Simian virus 40 and human pleural mesothelioma. Thorax 1999;54:60–61.

    Article  PubMed  CAS  Google Scholar 

  6. Zielhuis RL, Versteeg JP, Planteijdt HT. Pleura mesothelioma and exposure to asbestos. A retrospective case-control study in the Netherlands. Int Arch Occup Environ Health 1975;36:1–18.

    Article  PubMed  CAS  Google Scholar 

  7. Gaudichet A, Jaurand MC, Atassi K, et al. Apport du lavage bronchoalveolaire dans l’etude des relations fibres-microenvironnement alveolaire dans l’asbestose pulmonaire. INSERM 1979;84:381–394.

    CAS  Google Scholar 

  8. Walker AM, Loughlin JE, Friedlander ER, Rothman KJ, Dreyer NA. Projections of asbestos-related disease 1980–2009. J Occup Med 1983;25:409–425.

    PubMed  CAS  Google Scholar 

  9. McDonald AD, McDonald JC. Malignant mesothelioma in North America. Cancer 1980;46:1650–1656.

    Article  PubMed  CAS  Google Scholar 

  10. Grundy GW, Miller RW. Malignant mesothelioma in childhood: report of 13 cases. Cancer 1972;30:1216–1218.

    Article  PubMed  CAS  Google Scholar 

  11. Lafuma J, Hirsch A, Monchaux G, et al. Mesothelioma induced by intrapleural injection of different types of fibres in the rat. Synergistic effect of other carcinogens. In: Wagner JC, ed. Biological Effects of Mineral Fibres. Lyon: IARC Scientific Publication, 1980:311–322.

    Google Scholar 

  12. Park JF, Howard EB, Bair WJ. Acute toxicity of inhaled 238PuO2 in beagles. BNWL-1050. BNLW Rep 1970;Jan:3.6+.

    Google Scholar 

  13. Sanders CL, Jackson TA. Induction of mesotheliomas and sarcomas from “hot spots” of 239PuO2 activity. Health Phys 1972;22:755–759.

    PubMed  CAS  Google Scholar 

  14. Sanders CL. Pleural mesothelioma in the rat following exposure to 239PuO2. Health Phys 1992;63:695–697.

    Article  PubMed  CAS  Google Scholar 

  15. Hahn FF, Lundgren DL. Pulmonary neoplasms in rats that inhaled cerium-144 dioxide. Toxicol Pathol 1992;20:169–178.

    Article  PubMed  CAS  Google Scholar 

  16. Warren S, Brown CE, Chute RN, Federman M. Mesothelioma relative to asbestos, radiation and methylcholanthrene. Arch Pathol Lab Med 1981;105:305–312.

    PubMed  CAS  Google Scholar 

  17. Mossman KL. Ionizing radiation and cancer. Cancer Invest 1984;2:301–310.

    PubMed  CAS  Google Scholar 

  18. Kohn HI, Fry RJM. Radiation carcinogenesis. N Engl J Med 1984;310:504–511.

    Article  PubMed  CAS  Google Scholar 

  19. Kato H, Schull WJ. Studies of the mortality of A-bomb survivors. Mortality 1950–1978. Part I. Cancer mortality. Radiat Res 1982;90:395–432.

    PubMed  CAS  Google Scholar 

  20. Wakabayashi T, Kato H, Ikeda T. Studies of the mortality of the A-bomb survivors: Report 7: Part III. Incidence of cancer in 1959–1978, based on the tumor registry, Nagasaki. Radiat Res 1983;93:112–146.

    PubMed  CAS  Google Scholar 

  21. Harwood AR, Yaffe M. Cancer in man after diagnostic or therapeutic irradiation. In: Penn I, ed. Cancer Surveys, vol 1. Oxford: Oxford University Press, 1982:703–731.

    Google Scholar 

  22. Li FP, Cassady JR, Jaffe N. Risk of second tumors in survivors of childhood cancer. Cancer 1975;35:1230–1235.

    Article  PubMed  CAS  Google Scholar 

  23. Meadows AT, D’Angio GJ, Evans AE, Harris CC, Miller JC, Mike V. Oncogenesis and other late effects of cancer treatment in children: report of a single hospital study. Radiology 1975;114:175–180.

    PubMed  CAS  Google Scholar 

  24. Tefft M, Vawter GF, Mitus A. Second primary neoplasms in children. Am J Roentgenol Radium Ther Nucl Med 1968;103:820–822.

    Google Scholar 

  25. Meadows AT, D’Angio GJ, Mike V. Patterns of second malignant neoplasms in children. Cancer 1977;40:1903–1911.

    Article  PubMed  CAS  Google Scholar 

  26. Meadows AT, Strong LC, Li FP. Bone sarcoma as a second malignant neoplasm in children: influence of radiation and genetic predisposition. Cancer 1980;46:2603–2606.

    Article  PubMed  CAS  Google Scholar 

  27. Robinson E, Neugut AI, Wylie P. Clinical aspects of postirradiation sarcomas. J Natl Cancer Inst 1988;80:233–240.

    PubMed  CAS  Google Scholar 

  28. Kim JH, Chu FC, Woodard HQ, Melamed MR, Huvos A, Cantin J. Radiation-induced soft tissue and bone sarcoma. Radiology 1978;129:501–508.

    PubMed  CAS  Google Scholar 

  29. Mike V, Meadows AT, D’Angio GJ. Incidence of second malignant neoplasms in children: results of an international study. Lancet 1982;2:1326–1331.

    Article  PubMed  CAS  Google Scholar 

  30. Antman KH, Blum RH, Greenberger JS, Flowerdew G, Skarin AT, Canellos GP. Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med 1980;68:356–362.

    Article  PubMed  CAS  Google Scholar 

  31. Beckenbach H, van Kaick G, Wenz W. Zur diagnostik und therapie von thorotrastinduzierten tumoren. Z Krebsforsch 1970;74:318.

    Article  PubMed  CAS  Google Scholar 

  32. Dahlgren S. Effects of locally deposited colloidal thorium dioxide. Ann NY Acad Sci 1967;145:786–790.

    PubMed  CAS  Google Scholar 

  33. Maurer RM, Egloff B. Malignant peritoneal mesothelioma after cholangiography with Thorotrast. Cancer 1975;36:1381–1385.

    Article  PubMed  CAS  Google Scholar 

  34. Andersson M, Storm HH. Cancer incidence among Danish Thorotrast-exposed patients. J Natl Cancer Inst 1992;84:1318–1325.

    PubMed  CAS  Google Scholar 

  35. Van Kaick G, Wesch H, Luhrs H. The German Thorotrast study—report on 20 years follow-up. In: Risks from Radium and Thorotrast. BIR report 21. London: British Institute of Radiology, 1989;98–104.

    Google Scholar 

  36. Babcock TL, Powell DH, Bothwell RS. Radiation-induced peritoneal mesothelioma. J Surg Oncol 1976;8:369–372.

    PubMed  CAS  Google Scholar 

  37. Li FP. Second malignant tumors after cancer in childhood. Cancer 1977;40:1899–1902.

    Article  PubMed  CAS  Google Scholar 

  38. Brody RS, Schottenfeld D, Reid A. Multiple primary cancer risk after therapy for Hodgkin’s disease. Cancer 1977;40:1917–1926.

    Article  PubMed  CAS  Google Scholar 

  39. Stock RJ, Fu YS, Carter JR. Malignant peritoneal mesothelioma following radiotherapy for seminoma of the testis. Cancer 1979;44:914–919.

    Article  PubMed  CAS  Google Scholar 

  40. Brenner J, Sordillo PP, Magill GB, Golbey RB. Malignant mesothelioma of the pleura: review of 123 patients. Cancer 1982;49:2431–2435.

    Article  PubMed  CAS  Google Scholar 

  41. Hirsch A, Brochard P, De Cremoux H, et al. Features of asbestos-exposed and unexposed mesothelioma. Am J Ind Med 1982;3:413–422.

    PubMed  CAS  Google Scholar 

  42. Antman KH, Corson JM, Li FP, et al. Malignant mesothelioma following radiation exposure. J Clin Oncol 1983;1:695–700.

    PubMed  CAS  Google Scholar 

  43. Hoffman RS, Rossof AH, Pazdur R, Slayton R.E. Multiple primary malignancies (letter). J Clin Oncol 1983;2:1308.

    Google Scholar 

  44. Beier KM, Gallup DG, Burgess R, Stock RJ. Occurrence of malignant peritoneal mesothelioma after surgery and irradiation for cervical cancer. Gynecol Oncol 1984;17:375–380.

    Article  PubMed  CAS  Google Scholar 

  45. Tester WJ, Kinsella TJ, Waller B, et al. Second malignant neoplasms complicating Hodgkin’s disease: the National Cancer Institute experience. J Clin Oncol 1984;2:762–769.

    PubMed  CAS  Google Scholar 

  46. Antman KH, Ruxer RL, Aisner J, Vawter G. Mesothelioma following Wilms’ tumor in childhood. Cancer 1984;54:367–369.

    Article  PubMed  CAS  Google Scholar 

  47. Efremidis AP, Waxman JS, Chahinian AP. Association of lymphocytic neoplasia and mesothelioma. Cancer 1985;55:1056–1059.

    Article  PubMed  CAS  Google Scholar 

  48. Anderson KA, Hurley WC, Hurley BT, Ohrt DW. Malignant pleural mesothelioma following radiotherapy in a 16-year-old boy. Cancer 1985;56:273–276.

    Article  PubMed  CAS  Google Scholar 

  49. Austin MB, Fechner RE, Roggli VL. Pleural malignant mesothelioma following Wilms’ tumor. Am J Clin Pathol 1986;86:227–230.

    PubMed  CAS  Google Scholar 

  50. Gilks B, Hegedus C, Freeman H, Fratkin L, Churg A. Malignant peritoneal mesothelioma after remote abdominal radiation. Cancer 1988;61:2019–2021.

    Article  PubMed  CAS  Google Scholar 

  51. Kawashima A, Libshitz HI, Lukeman JM. Radiation-induced malignant pleural mesothelioma. Can Assoc Radiol J 1990;41:384–386.

    PubMed  CAS  Google Scholar 

  52. Horie A, Hiraoka K, Yamamoto O, Haratake J, Tsuchiya T, Sugimoto H. An autopsy case of peritoneal malignant mesothelioma in a radiation technologist. Acta Pathol Jpn 1990;40:57–62.

    PubMed  CAS  Google Scholar 

  53. Lerman Y, Learman Y, Schachter P, Herceg E, Lieberman Y, Yellin A. Radiation associated malignant pleural mesothelioma. Thorax 1991;46:463–464.

    Article  PubMed  CAS  Google Scholar 

  54. Hofmann J, Mintzer D, Warhol MJ. Malignant mesothelioma following radiation therapy. Am J Med 1994;97:379–382.

    Article  PubMed  CAS  Google Scholar 

  55. Shannon VR, Nesbitt JC, Libshitz HI. Malignant pleural mesothelioma after radiation therapy for breast cancer: a report of two additional patients. Cancer 1995;76:437–441.

    Article  PubMed  CAS  Google Scholar 

  56. Weissmann LB, Corson JM, Neugut AI, Antman KH. Malignant mesothelioma following treatment for Hodgkin’s disease. J Clin Oncol 1996;14:2098–2100.

    PubMed  CAS  Google Scholar 

  57. Cavazza A, Travis LB, Travis WD, et al. Post-irradiation malignant mesothelioma. Cancer 1996;77:1379–1385.

    Article  PubMed  CAS  Google Scholar 

  58. Pappo AS, Santana VM, Furman WL, et al. Post-irradiation malignant mesothelioma. Cancer 1997;79:192–193.

    Article  PubMed  CAS  Google Scholar 

  59. Amin AMH, Mason C, Rowe P. Diffuse malignant mesothelioma of the peritoneum following abdominal radiotherapy. Eur J Surg Oncol 2001;27:214–222.

    Article  PubMed  CAS  Google Scholar 

  60. Velissaris TJ, Tang ATM, Millward-Sadler GH, Morgan JM, Tsang GM. Pericardial mesothelioma following mantle field radiotherapy. J Cardiovasc Surg 2001;42:425–427.

    CAS  Google Scholar 

  61. Tucker MA, Coleman CN, Cox RS. Risk of second cancers after treatment for Hodgkin’s disease. N Engl J Med 1988;318:76–81.

    Article  PubMed  CAS  Google Scholar 

  62. Fisher RI, Devita VT, Bostick F, et al. Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin’s disease. Ann Intern Med 1980;92:595–599.

    PubMed  CAS  Google Scholar 

  63. Valagussa P, Santoro A, Fossati-Bellani F, Banfi A, Bonadonna G. Second acute leukemia and other malignancies following treatment for Hodgkin’s disease. J Clin Oncol 1986;4:830–837.

    PubMed  CAS  Google Scholar 

  64. Meadows AT, Baum E, Fossati-Bellani F, et al. Second malignant neoplasms in children: an update from the Late Effects Study Group. J Clin Oncol 1985;3:532–538.

    PubMed  CAS  Google Scholar 

  65. D’Angio GJ, Beckwith JB, Breslow NE. Wilms’ tumor: an update. Cancer 1980;45:1791–1798.

    PubMed  CAS  Google Scholar 

  66. Knudson AG, Strong LC. Mutation and cancer: a model for Wilms’ tumor of the kidney. J Natl Cancer Inst 1972;48:313–324.

    PubMed  Google Scholar 

  67. Myers MH, Heise HW, Li FP, Miller RW. Trends in cancer survival among U.S. white children, 1955–1971. J Pediatr 1975;87:815–818.

    Article  PubMed  CAS  Google Scholar 

  68. Ruffie P, Feld R, Minkin S, et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 332 patients. J Clin Oncol 1989;7:1157–1168.

    PubMed  CAS  Google Scholar 

  69. Roberts MM, Bell R. Acute leukemia after immunosuppressive therapy. Lancet 1976;2:768–770.

    Article  PubMed  CAS  Google Scholar 

  70. Schein PS, Winokur SH. Immunosuppressive and cytotoxic chemotherapy—long-term complications. Ann Intern Med 1975;82:84–95.

    PubMed  CAS  Google Scholar 

  71. Silvergleid AJ, Schrier SL. Acute myelogenous leukemia in two patients treated with azathioprine for nonmalignant diseases. Am J Med 1974;57:885–888.

    Article  PubMed  CAS  Google Scholar 

  72. Sotrel G, Jafari K, Lash AF, Stepto RC. Acute leukemia in advanced ovarian carcinoma after treatment with alkylating agents. Obstet Gynecol 1976;47:67–70.

    Google Scholar 

  73. Wall RL, Clausen KP. Carcinoma of the urinary bladder in patients receiving cyclophosphamide. N Engl J Med 1975;293:271–273.

    Article  PubMed  CAS  Google Scholar 

  74. Elmes PC, Simpson MJC. The clinical aspects of mesothelioma. Q J Med 1976;45:427–449.

    PubMed  CAS  Google Scholar 

  75. Scully RE, Antman KH. Protocol for the examination of specimens from patients with tumors of the peritoneum: a basis for checklists. Arch Pathol Lab Med 2001;125:1174–1176.

    PubMed  CAS  Google Scholar 

  76. McDonald AD, McDonald JC. Epidemiologic surveillance of mesothelioma in Canada. Canadian Med Assoc J 1973;109:359–362.

    CAS  Google Scholar 

  77. Connelly RR, Spirtas R, Myers MH, Percy CL, Fraumeni JF Jr. Demographic patterns for mesothelioma in the United States. J Natl Cancer Inst 1987;78:1053–1060.

    PubMed  CAS  Google Scholar 

  78. Neugut AI, Ahsan H, Antman KH. Incidence of malignant pleural mesothelioma after thoracic radiotherapy. Cancer 1997;80:948–950.

    Article  PubMed  CAS  Google Scholar 

  79. Committee on the Biologic Effects of Ionizing Radiations (BEIR V), National Research Council. Health Effects of Exposure to Low Levels of Ionizing Radiation. Washington, DC: National Academy Press, 1990.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Oncology, Columbia University Medical Center, New York, NY, USA

    Katherine D. Crew MD

  2. Department of Medicine and Epidemiology, Columbia University Medical Center, New York, NY, USA

    Alfred I. Neugut MD, PhD

  3. Departments of Medicine and Pharmacology, Columbia University, College of Physicians and Surgeons, New York, NY, USA

    Karen H. Antman MD

Authors
  1. Katherine D. Crew MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alfred I. Neugut MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Karen H. Antman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Thoracic Oncology, Barbara Ann Karmanos Cancer Institute, Harper University Hospital, USA

    Harvey I. Pass MD (Chief and Professor of Surgery and Oncology) (Chief and Professor of Surgery and Oncology)

  2. Wayne State University School of Medicine, Detroit, MI, 48201, USA

    Harvey I. Pass MD (Chief and Professor of Surgery and Oncology) (Chief and Professor of Surgery and Oncology)

  3. Nevada Cancer Institute, USA

    Nicholas J. Vogelzang MD (Director and Clinical Professor) (Director and Clinical Professor)

  4. Department of Internal Medicine, University of Nevada School of Medicine, Las Vegas, NV, 81935, USA

    Nicholas J. Vogelzang MD (Director and Clinical Professor) (Director and Clinical Professor)

  5. Thoracic Oncology, Cardinal Bernardin Cancer Center, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, 60153, USA

    Michele Carbone MD, PhD (Professor of Pathology, Director) (Professor of Pathology, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Science+Business Media, Inc.

About this chapter

Cite this chapter

Crew, K.D., Neugut, A.I., Antman, K.H. (2005). Malignant Mesothelioma Following Radiation. In: Pass, H.I., Vogelzang, N.J., Carbone, M. (eds) Malignant Mesothelioma. Springer, New York, NY. https://doi.org/10.1007/0-387-28274-2_21

Download citation

  • DOI: https://doi.org/10.1007/0-387-28274-2_21

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-22949-2

  • Online ISBN: 978-0-387-28274-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation